Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Dobucor
2. Dobuject
3. Dobutamin Fresenius
4. Dobutamin Hexal
5. Dobutamin Ratiopharm
6. Dobutamin Solvay
7. Dobutamin-ratiopharm
8. Dobutamina Inibsa
9. Dobutamina Rovi
10. Dobutamine
11. Dobutamine (+)-isomer
12. Dobutamine Hydrobromide
13. Dobutamine Lactobionate
14. Dobutamine Phosphate (1:1) Salt, (-)-isomer
15. Dobutamine Tartrate
16. Dobutamine Tartrate (1:1), (r-(r*,r*))-isomer
17. Dobutamine Tartrate (1:1), (s-(r*,r*))-isomer
18. Dobutamine, (-)-isomer
19. Dobutamine, Phosphate (1:1) Salt (+)-isomer
20. Dobutrex
21. Hydrobromide, Dobutamine
22. Hydrochloride, Dobutamine
23. Lactobionate, Dobutamine
24. Lilly 81929
25. Oxiken
26. Posiject
27. Tartrate, Dobutamine
1. 49745-95-1
2. Dobutamine Hcl
3. Dobutrex
4. Inotrex
5. Dobutamine (hydrochloride)
6. Dl-dobutamine Hydrochloride
7. 52663-81-7
8. Nsc-299583
9. Rac Dobutamine Hydrochloride
10. 0wr771djxv
11. 1,2-benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, Hydrochloride (1:1)
12. 49745-95-1 (hcl)
13. 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol Hydrochloride
14. 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol;hydrochloride
15. (+-)-4-(2-((3-(p-hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol Hydrochloride
16. Chebi:4671
17. 4-(2-((4-(4-hydroxyphenyl)butan-2-yl)amino)ethyl)benzene-1,2-diol Hydrochloride
18. Smr000058435
19. Dobutamina Clorhidrato [spanish]
20. Sr-01000075265
21. Ly 81929
22. Einecs 256-464-1
23. Unii-0wr771djxv
24. Nsc 299583
25. Ly 46236
26. Posiject
27. 1,2-benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, Hydrochloride
28. 1,2-benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, Hydrochloride
29. 4-(2-(4-(4-hydroxyphenyl)butan-2-ylamino)ethyl)benzene-1,2-diol Hydrochloride
30. 4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol Hydrochloride
31. S-1000
32. Dobutrex (tn)
33. 1,2-benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, Hydrochloride (1:1)
34. Prestwick_741
35. Mfcd00153795
36. 1,2-benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-
37. Dobutamine Hydrochloride In Dextrose 5%
38. Dobutamine Hydrochloride [usan:usp:ban:jan]
39. Schembl41609
40. 1,2-benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, Hydrochloride, (+-)-
41. Mls000860012
42. Mls001332503
43. Mls001332504
44. Mls002222253
45. Regid_for_cid_65324
46. Chembl1200418
47. Dtxsid30964383
48. Dobutamine Hydrochloride, >=98%
49. Dobutamine Hydrochloride In Dextrose 5% In Plastic Container
50. Hms1569g05
51. Bcp13026
52. Tox21_500365
53. Dobutamine Hydrochloride [mi]
54. Nsc299583
55. Dobutamine Hydrochloride (jp17/usp)
56. Dobutamine Hydrochloride [jan]
57. Akos015907731
58. Ccg-220352
59. Ccg-221669
60. Dobutamine Hydrochloride [usan]
61. Ks-1050
62. Lp00365
63. (.+-.)-4-[2-[[3-(p-hydroxyphenyl)-1-methylpropyl]amino]ethyl]pyrocatechol Hydrochloride
64. 4-(2-((3-(p-hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatecholhydrochloride
65. Dobutamine Hydrochloride [mart.]
66. Dobutamine Hydrochloride [who-dd]
67. Ncgc00093799-01
68. Ncgc00093799-02
69. Ncgc00261050-01
70. Ac-11653
71. Hy-15746
72. Ly-46236
73. Db-051684
74. D4335
75. Eu-0100365
76. Ft-0625557
77. Ft-0681170
78. Dobutamine Hydrochloride [ep Impurity]
79. Dobutamine Hydrochloride [orange Book]
80. D 0676
81. D00632
82. Dobutamine Hydrochloride [ep Monograph]
83. Dobutamine Hydrochloride [usp Impurity]
84. Dobutamine Hydrochloride [usp Monograph]
85. 368d042
86. A827836
87. Sr-01000075265-1
88. Sr-01000075265-3
89. Sr-01000075265-6
90. W-106009
91. Q27106435
92. Dobutamine Hydrochloride, British Pharmacopoeia (bp) Reference Standard
93. Dobutamine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
94. 1, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, Hydrochloride, (.+-.)-
95. 3,4-dihydroxy-n-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenethylamine Hydrochloride
96. 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]aminoethyl-1,2-benzenediol Hydrochloride
97. Dobutamine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
98. ( Inverted Question Mark)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol Hydrochloride
99. (+/-)-4-(2-((3-(p-hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol Hydrochloride
100. 1,2-benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, Hydrochloride, (+/-)-
Molecular Weight | 337.8 g/mol |
---|---|
Molecular Formula | C18H24ClNO3 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 7 |
Exact Mass | 337.1444713 g/mol |
Monoisotopic Mass | 337.1444713 g/mol |
Topological Polar Surface Area | 72.7 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 305 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Dobutamine hydrochloride |
Drug Label | Dobutamine Hydrochloride in 5% Dextrose Injection is a sterile, nonpyrogenic solution of Dobutamine Hydrochloride, USP and Dextrose, USP in Water for Injection, USP. Dobutamine hydrochloride is chemically designated as ()-4-[2-[[3-(p-hydroxyphenyl)... |
Active Ingredient | Dobutamine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 12.5mg base/ml |
Market Status | Prescription |
Company | Hospira; Eurohlth Intl |
2 of 2 | |
---|---|
Drug Name | Dobutamine hydrochloride |
Drug Label | Dobutamine Hydrochloride in 5% Dextrose Injection is a sterile, nonpyrogenic solution of Dobutamine Hydrochloride, USP and Dextrose, USP in Water for Injection, USP. Dobutamine hydrochloride is chemically designated as ()-4-[2-[[3-(p-hydroxyphenyl)... |
Active Ingredient | Dobutamine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 12.5mg base/ml |
Market Status | Prescription |
Company | Hospira; Eurohlth Intl |
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Adrenergic beta-1 Receptor Agonists
Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Agonists.)
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8856
Submission : 1990-11-20
Status : Active
Type : II
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12528
Submission : 1997-05-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8589
Submission : 1990-06-05
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10296
Submission : 1993-06-14
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9024
Submission : 1991-03-13
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9888
Submission : 1992-10-02
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-05-04
Pay. Date : 2022-04-29
DMF Number : 9762
Submission : 1992-07-02
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10706
Submission : 1994-01-28
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9483
Submission : 1992-01-10
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9369
Submission : 1991-09-30
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?